View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Haselmeier|2 May 2019

i-pen Reusable, Variable-dose Injection Device

The i-pen injects standard 3ml cartridges of insulin in variable doses.

The i-pen injects standard 3ml cartridges of insulin in variable doses.

It offers a range of colours and its design was tested specifically for self-injecting patients through detailed research and patient-testing. It is available in Haselmeier’s design, but it is also customisable to the patient’s needs. The pen is also re-usable.


  • The pen has a compact design and can be held and stored easily. It is also portable for 24/7 protection
  • It is made of anodized aluminium, ensuring a durable product that is reliable and consistent
  • It can handle variable-dose and multiple injections
  • Its dose indicator is large and can be read easily
  • The dose correction feature reduces incorrect injection dosing and loss of product
  • It has a manual insertion and injection in dose increments from 0.01ml to 0.6ml

Applications of the i-pen include the BerliPen is an insulin injection device, which is both functional and has high aesthetical value. With its anodized aluminium body and high-calibre look, the pen shows its innovative design. Its drive system and ball bearing ensure a precise and easy application. It also has safety-dosing where the pen will make a sound when being used.

Type 2 diabetes is a global health problem. According to expert estimates, the number of patients worldwide will increase by 48% by 2045.
The D-Flex injection pen can do more than previous pens. D-Flex can be configured for several fixed-dose values and is thus a variable fixed-dose pen.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology